These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26091447)

  • 41. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma.
    Singh J; Wozniak A; Cotler SJ; Dhanarajan A; Aldrich D; Park D; Kasia C; Schmidt B; Scaglione S
    J Clin Gastroenterol; 2022 Apr; 56(4):369-373. PubMed ID: 33883511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Case-control Study.
    German MN; Lutz MK; Pickhardt PJ; Bruce RJ; Said A
    J Clin Gastroenterol; 2020 Sep; 54(8):733-740. PubMed ID: 31567625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.
    Zhang ZJ; Zheng ZJ; Shi R; Su Q; Jiang Q; Kip KE
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2347-53. PubMed ID: 22523334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.
    Nkontchou G; Cosson E; Aout M; Mahmoudi A; Bourcier V; Charif I; Ganne-Carrie N; Grando-Lemaire V; Vicaut E; Trinchet JC; Beaugrand M
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2601-8. PubMed ID: 21752887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.
    Hydes TJ; Cuthbertson DJ; Graef S; Berhane S; Teng M; Skowronska A; Singh P; Dhanaraj S; Tahrani A; Johnson PJ
    Clin Ther; 2022 Feb; 44(2):257-268. PubMed ID: 35078642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
    Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
    J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
    Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
    Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients.
    Lehman DM; Lorenzo C; Hernandez J; Wang CP
    Diabetes Care; 2012 May; 35(5):1002-7. PubMed ID: 22456867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
    Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
    J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back.
    Yilmaz Y; Colak Y; Kurt R; Senates E; Eren F
    Tumori; 2013; 99(1):10-6. PubMed ID: 23548993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
    Gao C; Fang L; Zhao HC; Li JT; Yao SK
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
    Inoue M; Yoshimi I; Sobue T; Tsugane S;
    J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.
    Chang Y; Liu Q; Zhou Z; Ding Y; Yang M; Xu W; Chen K; Zhang Q; Wang Z; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820934881. PubMed ID: 32552476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
    Wang J; Li X
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
    Lu HL; Su YC; Lin MC; Sun MF; Huang ST
    Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
    Del Campo JA; García-Valdecasas M; Gil-Gómez A; Rojas Á; Gallego P; Ampuero J; Gallego-Durán R; Pastor H; Grande L; Padillo FJ; Muntané J; Romero-Gómez M
    PLoS One; 2018; 13(1):e0191805. PubMed ID: 29385181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.
    Hung CH; Lee CM; Wang JH; Hu TH; Chen CH; Lin CY; Lu SN
    Int J Cancer; 2011 May; 128(10):2344-52. PubMed ID: 20669224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.